Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Virobay Inc.
DescriptionReversible inhibitor of cathepsin B
Molecular Target Cathepsin B
Mechanism of ActionCathepsin B inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationLiver fibrosis
Indication DetailsTreat liver fibrosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today